Mid-cap biotechs join Trump’s latest round of drug pricing deals
BioPharma Dive
Focused on Medicaid, the new pacts now involve more than just large pharmaceutical companies, but still aren t expected to meaningfully impact drugmaker profits.
pharminent
September 1, 2026 (Last updated: September 2, 2026)
BioPharma Dive
Focused on Medicaid, the new pacts now involve more than just large pharmaceutical companies, but still aren t expected to meaningfully impact drugmaker profits.